Xvivo Perfusion 将来の成長
Future 基準チェック /36
Xvivo Perfusion利益と収益がそれぞれ年間13.4%と30.1%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に11.5% 16.8%なると予測されています。
主要情報
13.4%
収益成長率
16.8%
EPS成長率
| Medical Equipment 収益成長 | 32.7% |
| 収益成長率 | 30.1% |
| 将来の株主資本利益率 | 11.5% |
| アナリストカバレッジ | Good |
| 最終更新日 | 25 Oct 2024 |
今後の成長に関する最新情報
Recent updates
Xvivo Perfusion (STO:XVIVO) Is Posting Healthy Earnings, But It Is Not All Good News
Nov 04
Results: Xvivo Perfusion AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts
Oct 27With Xvivo Perfusion AB (publ) (STO:XVIVO) It Looks Like You'll Get What You Pay For
Oct 25Is There An Opportunity With Xvivo Perfusion AB (publ)'s (STO:XVIVO) 40% Undervaluation?
Aug 03Xvivo Perfusion AB (publ) (STO:XVIVO) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected
Apr 25There Are Reasons To Feel Uneasy About Xvivo Perfusion's (STO:XVIVO) Returns On Capital
Apr 11Need To Know: Analysts Just Made A Substantial Cut To Their Xvivo Perfusion AB (publ) (STO:XVIVO) Estimates
Feb 05We Think That There Are Issues Underlying Xvivo Perfusion's (STO:XVIVO) Earnings
Feb 01Earnings Beat: Xvivo Perfusion AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jan 28Returns On Capital At Xvivo Perfusion (STO:XVIVO) Have Stalled
Aug 24Why Xvivo Perfusion AB (publ) (STO:XVIVO) Could Be Worth Watching
Jul 17Do Xvivo Perfusion's (STO:XVIVO) Earnings Warrant Your Attention?
Jun 16Xvivo Perfusion (STO:XVIVO) May Have Issues Allocating Its Capital
Apr 19Are Investors Undervaluing Xvivo Perfusion AB (publ) (STO:XVIVO) By 21%?
Mar 23With EPS Growth And More, Xvivo Perfusion (STO:XVIVO) Makes An Interesting Case
Mar 07When Should You Buy Xvivo Perfusion AB (publ) (STO:XVIVO)?
Feb 13Be Wary Of Xvivo Perfusion (STO:XVIVO) And Its Returns On Capital
Dec 14Is There An Opportunity With Xvivo Perfusion AB (publ)'s (STO:XVIVO) 35% Undervaluation?
Nov 17Xvivo Perfusion (STO:XVIVO) Might Be Having Difficulty Using Its Capital Effectively
Aug 20Statutory Profit Doesn't Reflect How Good Xvivo Perfusion's (STO:XVIVO) Earnings Are
Jul 21Be Wary Of Xvivo Perfusion (STO:XVIVO) And Its Returns On Capital
Mar 30At kr258, Is Xvivo Perfusion AB (publ) (STO:XVIVO) Worth Looking At Closely?
Feb 18A Look At The Fair Value Of Xvivo Perfusion AB (publ) (STO:XVIVO)
Jan 30業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 12/31/2026 | 1,543 | 282 | 150 | 401 | 4 |
| 12/31/2025 | 1,129 | 171 | -4 | 244 | 6 |
| 12/31/2024 | 810 | 157 | -23 | 178 | 3 |
| 9/30/2024 | 751 | 204 | -118 | 67 | N/A |
| 6/30/2024 | 699 | 121 | -103 | 69 | N/A |
| 3/31/2024 | 643 | 100 | -93 | 60 | N/A |
| 12/31/2023 | 598 | 92 | -98 | 46 | N/A |
| 9/30/2023 | 573 | 24 | -72 | 50 | N/A |
| 6/30/2023 | 524 | 27 | -86 | 42 | N/A |
| 3/31/2023 | 463 | 28 | -108 | 25 | N/A |
| 12/31/2022 | 415 | 18 | -103 | 28 | N/A |
| 9/30/2022 | 370 | 30 | -127 | 6 | N/A |
| 6/30/2022 | 328 | 23 | -138 | -20 | N/A |
| 3/31/2022 | 293 | 7 | -138 | -32 | N/A |
| 12/31/2021 | 258 | 8 | -106 | -12 | N/A |
| 9/30/2021 | 233 | -24 | -116 | -33 | N/A |
| 6/30/2021 | 221 | -37 | -104 | -27 | N/A |
| 3/31/2021 | 192 | -44 | -79 | -11 | N/A |
| 12/31/2020 | 180 | -44 | -77 | -12 | N/A |
| 9/30/2020 | 182 | -26 | -68 | 3 | N/A |
| 6/30/2020 | 194 | -6 | -54 | 20 | N/A |
| 3/31/2020 | 220 | 12 | -49 | 39 | N/A |
| 12/31/2019 | 221 | 5 | -54 | 30 | N/A |
| 9/30/2019 | 217 | 12 | -37 | 34 | N/A |
| 6/30/2019 | 203 | 7 | -42 | 23 | N/A |
| 3/31/2019 | 193 | 9 | -41 | 15 | N/A |
| 12/31/2018 | 188 | 13 | -31 | 24 | N/A |
| 9/30/2018 | 171 | 13 | -21 | 34 | N/A |
| 6/30/2018 | 162 | 13 | N/A | 38 | N/A |
| 3/31/2018 | 153 | 10 | N/A | 33 | N/A |
| 12/31/2017 | 148 | 6 | N/A | 22 | N/A |
| 9/30/2017 | 145 | 0 | N/A | 8 | N/A |
| 6/30/2017 | 145 | 0 | N/A | 6 | N/A |
| 3/31/2017 | 142 | 0 | N/A | 5 | N/A |
| 12/31/2016 | 138 | 2 | N/A | 13 | N/A |
| 9/30/2016 | 132 | 5 | N/A | 22 | N/A |
| 6/30/2016 | 127 | 7 | N/A | 19 | N/A |
| 3/31/2016 | 122 | 6 | N/A | 20 | N/A |
| 12/31/2015 | 120 | 5 | N/A | 9 | N/A |
| 9/30/2015 | 113 | 4 | N/A | -1 | N/A |
| 6/30/2015 | 109 | 4 | N/A | 1 | N/A |
| 3/31/2015 | 98 | 3 | N/A | -7 | N/A |
| 12/31/2014 | 85 | 5 | N/A | -5 | N/A |
| 9/30/2014 | 79 | 6 | N/A | 9 | N/A |
| 6/30/2014 | 74 | 7 | N/A | 3 | N/A |
| 3/31/2014 | 71 | 7 | N/A | 6 | N/A |
| 12/31/2013 | 69 | 8 | N/A | 13 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: XVIVOの予測収益成長率 (年間13.4% ) は 貯蓄率 ( 1.2% ) を上回っています。
収益対市場: XVIVOの収益 ( 13.4% ) Swedish市場 ( 15.6% ) よりも低い成長が予測されています。
高成長収益: XVIVOの収益は増加すると予測されていますが、大幅には増加しません。
収益対市場: XVIVOの収益 ( 30.1% ) Swedish市場 ( 0.06% ) よりも速いペースで成長すると予測されています。
高い収益成長: XVIVOの収益 ( 30.1% ) 20%よりも速いペースで成長すると予測されています。
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: XVIVOの 自己資本利益率 は、3年後には低くなると予測されています ( 11.5 %)。